Vet World   Vol.18   September-2025  Article - 8 

Research Article

Veterinary World, 18(9): 2650-2662

https://doi.org/10.14202/vetworld.2025.2650-2662

Foot-and-mouth disease in Armenia (1958–2003): Historical epidemiology, serotype dynamics, and evolving vaccination strategies

Henrik Voskanyan1, Liana Simonyan1 ORCID, Nelli Shahazizyan1, Mariam Mirzoyan1, Jon Simonyan2 ORCID, and Tigran Markosyan1 ORCID

1. Scientific Centre for Risk Assessment and Analysis in Food Safety Area, CJSC, Yerevan 0072, Republic of Armenia.

2. Department of Livestock Breeding, Ministry of Economy, Yerevan 0010, Republic of Armenia.

Background and Aim: Foot-and-mouth disease (FMD) is a highly contagious transboundary animal disease affecting clo­ven-hoofed livestock, with significant economic and trade implications. Armenia lies within the West Eurasia and Middle East epidemiological pool, where serotypes O, A, Asia-1, and occasionally SAT-2 circulate. Despite decades of control efforts, the historical epidemiology of FMD in Armenia has not been comprehensively documented. This study aimed to conduct a 65-year retrospective analysis of FMD in Armenia to characterize serotype distribution, outbreak patterns, vaccination strat­egies, and diagnostic advancements, and to identify priorities for progression in the progressive control pathway (PCP-FMD).

Materials and Methods: Data from 1958 to 2023 were compiled from the Union of Soviet Socialist Republics (USSR) agri­cultural archives, national veterinary records, World Organization for Animal Health/World Reference Laboratory for FMD reports, and peer-reviewed literature. Serotype identification, outbreak frequency, and species involvement were analyzed using descriptive statistics, heatmaps, and geographic information system (GIS) mapping. Diagnostic evolution from com­plement fixation testing to enzyme-linked immunosorbent assay, reverse transcription-polymerase chain reaction, and viral protein 1 (VP1) sequencing was documented. Vaccination protocols were traced from early monovalent campaigns to cur­rent polyvalent strategies.

Results: Between 1958 and 2023, Armenia recorded over 1 million FMD cases, with peaks in 1966 (591,820 cases) and 1973 (471,263 cases). Serotypes O, A, Asia-1, and SAT-1 were detected, with serotype O predominating. Outbreaks declined significantly after the 1980s, coinciding with mass vaccination, improved diagnostics, and targeted biosecurity measures. Notable milestones included integration of the A/Armenia/98 strain into vaccines (1999) and adoption of polyvalent vac­cines containing the A/ASIA/G-VII lineage (2016). No outbreaks have been reported since 2016.

Conclusion: Armenia’s sustained control of FMD reflects adaptive vaccination strategies, early serotype detection, and regional cooperation. Progression from PCP-FMD Stage 2 to Stage 3 will require enhanced vaccination coverage, expanded surveillance, and strengthened veterinary infrastructure. Historical lessons from Armenia’s control strategies may inform FMD management in similar transboundary risk zones.

Keywords: Armenia, foot-and-mouth disease, outbreak history, progressive control pathway-foot-and-mouth disease, serotype, vaccination strategy.

How to cite this article: Voskanyan H, Simonyan L, Shahazizyan N, Mirzoyan M, Simonyan J, and Markosyan T (2025) Foot-and-mouth disease in Armenia (1958–2003): Historical epidemiology, serotype dynamics, and evolving vaccination strategies, Veterinary World, 18(9): 2650-2662.

Received: 30-04-2025   Accepted: 06-08-2025   Published online: 11-09-2025

Corresponding author: Tigran Markosyan    E-mail: tigran79hm@yandex.ru; tigran79hm@gmail.com

DOI: 10.14202/vetworld.2025.2650-2662

Copyright: Voskanyan, et al. This article is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.